melanotan 2 risks Unregulated peptide melanotan-II seen to increase risk of abnormal moles Seven Days Of Melanotan 2

(read here & here) I know of no controlled studies of either melatonin or lignan use in the treatment of Cushings disease in dogs

T.SpaceyS

A larger clinical trial randomly assigned more than 500 patients with type 2 diabetes and symptomatic peripheral neuropathy to one of the following treatments: (i) 600 mg/day of intravenous lipoic acid for three weeks followed by 1,800 mg/day of oral lipoic acid for six months, (ii) 600 mg/day of intravenous lipoic acid for three weeks followed by oral placebo for six months, or (iii) intravenous placebo for three weeks followed by oral placebo for six months (76)

Saliva-omics in plasma cell disorders- Proof of concept and potential as a non-invasive tool for monitoring disease burden